Literature DB >> 31124602

Investigation of Dipicolinic Acid Isosteres for the Inhibition of Metallo-β-Lactamases.

Allie Y Chen1, Pei W Thomas2, Zishuo Cheng3, Nasa Y Xu2, David L Tierney3, Michael W Crowder3, Walter Fast2, Seth M Cohen1.   

Abstract

New Delhi metallo-β-lactamase-1 (NDM-1) poses an immediate threat to our most effective and widely prescribed drugs, the β-lactam-containing class of antibiotics. There are no clinically relevant inhibitors to combat NDM-1, despite significant efforts toward their development. Inhibitors that use a carboxylic acid motif for binding the ZnII ions in the active site of NDM-1 make up a large portion of the >500 inhibitors reported to date. New and structurally diverse scaffolds for inhibitor development are needed urgently. Herein we report the isosteric replacement of one carboxylate group of dipicolinic acid (DPA) to obtain DPA isosteres with good inhibitory activity against NDM-1 (and related metallo-β-lactamases, IMP-1 and VIM-2). It was determined that the choice of carboxylate isostere influences both the potency of NDM-1 inhibition and the mechanism of action. Additionally, we show that an isostere with a metal-stripping mechanism can be re-engineered into an inhibitor that favors ternary complex formation. This work provides a roadmap for future isosteric replacement of routinely used metal binding motifs (i.e., carboxylic acids) for the generation of new entities in NDM-1 inhibitor design and development.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  New Delhi metallo-β-lactamase; dipicolinic acid; imipenemase-1; isosteres; metal binding pharmacophores; metallo-β-lactamases

Mesh:

Substances:

Year:  2019        PMID: 31124602      PMCID: PMC6609467          DOI: 10.1002/cmdc.201900172

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  51 in total

Review 1.  Emerging carbapenemases: a global perspective.

Authors:  Timothy R Walsh
Journal:  Int J Antimicrob Agents       Date:  2010-11       Impact factor: 5.283

2.  Probing the role of Asp-120(81) of metallo-beta-lactamase (IMP-1) by site-directed mutagenesis, kinetic studies, and X-ray crystallography.

Authors:  Yoshihiro Yamaguchi; Takahiro Kuroki; Hisami Yasuzawa; Toshihiro Higashi; Wanchun Jin; Akiko Kawanami; Yuriko Yamagata; Yoshichika Arakawa; Masafumi Goto; Hiromasa Kurosaki
Journal:  J Biol Chem       Date:  2005-03-23       Impact factor: 5.157

Review 3.  Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity.

Authors:  Jed F Fisher; Samy O Meroueh; Shahriar Mobashery
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

Review 4.  Metallo-beta-lactamases: novel weaponry for antibiotic resistance in bacteria.

Authors:  Michael W Crowder; James Spencer; Alejandro J Vila
Journal:  Acc Chem Res       Date:  2006-10       Impact factor: 22.384

5.  Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism.

Authors:  HongMin Zhang; Quan Hao
Journal:  FASEB J       Date:  2011-04-20       Impact factor: 5.191

Review 6.  Updated functional classification of beta-lactamases.

Authors:  Karen Bush; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

7.  Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?

Authors:  Patrice Nordmann; Laurent Poirel; Mark A Toleman; Timothy R Walsh
Journal:  J Antimicrob Chemother       Date:  2011-01-28       Impact factor: 5.790

8.  Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.

Authors:  Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

9.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

Review 10.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

View more
  9 in total

1.  Iminodiacetic Acid as a Novel Metal-Binding Pharmacophore for New Delhi Metallo-β-lactamase Inhibitor Development.

Authors:  Allie Y Chen; Caitlyn A Thomas; Pei W Thomas; Kundi Yang; Zishuo Cheng; Walter Fast; Michael W Crowder; Seth M Cohen
Journal:  ChemMedChem       Date:  2020-05-07       Impact factor: 3.466

2.  A Cephalosporin Prochelator Inhibits New Delhi Metallo-β-lactamase 1 without Removing Zinc.

Authors:  Abigail C Jackson; Jacqueline M Zaengle-Barone; Elena A Puccio; Katherine J Franz
Journal:  ACS Infect Dis       Date:  2020-04-29       Impact factor: 5.084

3.  Identification of Adenosine Deaminase Inhibitors by Metal-binding Pharmacophore Screening.

Authors:  Rebecca N Adamek; Paul Ludford; Stephanie M Duggan; Yitzhak Tor; Seth M Cohen
Journal:  ChemMedChem       Date:  2020-10-14       Impact factor: 3.466

4.  Visualizing the Dynamic Metalation State of New Delhi Metallo-β-lactamase-1 in Bacteria Using a Reversible Fluorescent Probe.

Authors:  Radhika Mehta; Dann D Rivera; David J Reilley; Dominique Tan; Pei W Thomas; Abigail Hinojosa; Alesha C Stewart; Zishuo Cheng; Caitlyn A Thomas; Michael W Crowder; Anastassia N Alexandrova; Walter Fast; Emily L Que
Journal:  J Am Chem Soc       Date:  2021-05-26       Impact factor: 16.383

5.  Spectroscopic and biochemical characterization of metallo-β-lactamase IMP-1 with dicarboxylic, sulfonyl, and thiol inhibitors.

Authors:  Huan Zhang; Kundi Yang; Zishuo Cheng; Caitlyn Thomas; Abbie Steinbrunner; Cecily Pryor; Maya Vulcan; Claire Kemp; Diego Orea; Chathura Paththamperuma; Allie Y Chen; Seth M Cohen; Richard C Page; David L Tierney; Michael W Crowder
Journal:  Bioorg Med Chem       Date:  2021-05-01       Impact factor: 3.461

Review 6.  Recent Advances in the Development of Semisynthetic Glycopeptide Antibiotics: 2014-2022.

Authors:  Emma van Groesen; Paolo Innocenti; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2022-07-27       Impact factor: 5.578

7.  Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment-based drug discovery.

Authors:  Christine N Morrison; Kathleen E Prosser; Ryjul W Stokes; Anna Cordes; Nils Metzler-Nolte; Seth M Cohen
Journal:  Chem Sci       Date:  2019-12-12       Impact factor: 9.969

8.  Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.

Authors:  Kamaleddin H M E Tehrani; Nora C Brüchle; Nicola Wade; Vida Mashayekhi; Diego Pesce; Matthijs J van Haren; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2020-04-03       Impact factor: 5.084

9.  MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo--Lactamase Inhibitors.

Authors:  Zishuo Cheng; Caitlyn A Thomas; Adam R Joyner; Robert L Kimble; Aidan M Sturgill; Nhu-Y Tran; Maya R Vulcan; Spencer A Klinsky; Diego J Orea; Cody R Platt; Fanpu Cao; Bo Li; Qilin Yang; Cole J Yurkiewicz; Walter Fast; Michael W Crowder
Journal:  Biomolecules       Date:  2020-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.